Timothy A. Springer - May 24, 2021 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Director, 10%+ Owner
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Stock symbol
SELB
Transactions as of
May 24, 2021
Transactions value $
$7,059,872
Form type
4
Date filed
5/26/2021, 05:21 PM
Previous filing
May 25, 2021
Next filing
Apr 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Purchase $1.99M +590K +3.42% $3.38 17.8M May 24, 2021 See Footnote F1, F2
transaction SELB Common Stock Purchase $1.36M +384K +2.15% $3.55 18.2M May 25, 2021 See Footnote F2, F3
transaction SELB Common Stock Purchase $3.71M +926K +5.08% $4.00 19.2M May 26, 2021 See Footnote F2, F4
holding SELB Common Stock 7.29M May 24, 2021 Direct
holding SELB Common Stock 86.4K May 24, 2021 By wife
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.19 to $3.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Held by TAS Partners LLC. The Reporting Person is the managing member of TAS Partners LLC. The Reporting Person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
F3 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.40 to $3.65. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.83 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.